Crystal structures
of two potential chemotherapeutic agents, namely
4-nitrobenzyl N′-(adamantan-1-yl)piperidine-1-carbothioimidate 1 and 4-bromobenzyl N′-(adamantan-1-yl)piperidine-1-carbothioimidate 2, have been analyzed in detail. X-ray analysis reveals that
the molecular conformations of these compounds are strikingly different.
These two structures are compared with two of their closely related
structures. In the related structures, morpholine replaces piperidine.
Based on the Hirshfeld surface analysis and two-dimensional (2D) fingerprint
plots, we describe the effects of piperidine/morpholine and Br/NO2 groups on the intermolecular interactions. An analysis of
the CLP-PIXEL energy provides insight into the energetics of the
dimers observed in the title compounds and their related structures.
Compound 1 stabilizes with bifurcated C–H···S,
C–H···O, and O(lp)···C(π)
interactions, whereas compound 2 stabilizes with C–H···N,
C–H···Br, and C–H···C
interactions. The energy frameworks for the crystal structures of
the title compounds reveal differences. The atoms-in-molecules (AIM)
analysis was performed to confirm the intermolecular interactions
found in the crystal structures of 1 and 2. Additionally, docking analysis suggests that the title compounds
bind at the active site of human sphingosine kinase 1, a well-known
cancer target.